- Home
- CHRW vs ICLR Comparison
CHRW vs ICLR Comparison
Compare CHRW & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- ICLR
- Stock Information
- Founded
- CHRW 1905
- ICLR 1990
- Country
- CHRW United States
- ICLR Ireland
- Employees
- CHRW N/A
- ICLR N/A
- Industry
- CHRW Oil Refining/Marketing
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CHRW Consumer Discretionary
- ICLR Health Care
- Exchange
- CHRW Nasdaq
- ICLR Nasdaq
- Market Cap
- CHRW 14.8B
- ICLR 14.3B
- IPO Year
- CHRW 1997
- ICLR 1998
- Fundamental
- Price
- CHRW $129.06
- ICLR $182.03
- Analyst Decision
- CHRW Buy
- ICLR Buy
- Analyst Count
- CHRW 21
- ICLR 15
- Target Price
- CHRW $132.15
- ICLR $211.36
- AVG Volume (30 Days)
- CHRW 1.4M
- ICLR 1.0M
- Earning Date
- CHRW 10-29-2025
- ICLR 10-22-2025
- Dividend Yield
- CHRW 1.97%
- ICLR N/A
- EPS Growth
- CHRW 58.22
- ICLR N/A
- EPS
- CHRW 4.40
- ICLR 7.47
- Revenue
- CHRW $17,012,580,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- CHRW N/A
- ICLR N/A
- Revenue Next Year
- CHRW $3.64
- ICLR $1.68
- P/E Ratio
- CHRW $28.66
- ICLR $23.83
- Revenue Growth
- CHRW N/A
- ICLR N/A
- 52 Week Low
- CHRW $84.68
- ICLR $125.10
- 52 Week High
- CHRW $138.00
- ICLR $242.72
- Technical
- Relative Strength Index (RSI)
- CHRW 44.27
- ICLR 45.58
- Support Level
- CHRW $125.35
- ICLR $173.47
- Resistance Level
- CHRW $130.16
- ICLR $198.30
- Average True Range (ATR)
- CHRW 2.96
- ICLR 7.23
- MACD
- CHRW -0.52
- ICLR -1.45
- Stochastic Oscillator
- CHRW 26.84
- ICLR 19.94
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.